Carol Bentley

Development of Therapeutic Anti-JAGGED1 Antibodies for Cancer Therapy

Massimo Masiero, Demin Li, Pat Whiteman et al. · Molecular Cancer Therapeutics · 2019 · 46 citations · Full text

Medicine, Cancer Biology, Oncology +16

Development of a T-cell Receptor Mimic Antibody against Wild-Type p53 for Cancer Immunotherapy

Demin Li, Carol Bentley, Amanda P. Anderson et al. · Cancer Research · 2017 · 36 citations · Full text

Life Sciences, Immunology, Oncology +17

Transient treatment with CDK inhibitors eliminates proliferative potential even when their abilities to evoke apoptosis and DNA damage are blocked

Simon Scrace, Peter Kierstan, Jenifer Borgognoni et al. · Cell Cycle · 2008 · 17 citations · Full text

Life Sciences, Cancer Biology, Oncology +17

Context-Dependent Cell Cycle Checkpoint Abrogation by a Novel Kinase Inhibitor

Andrew J. Massey, Jenifer Borgognoni, Carol Bentley et al. · PLoS ONE · 2010 · 12 citations · Full text

Life Sciences, Cell Biology, Oncology +17

Engineering chimeric human and mouse major histocompatibility complex (MHC) class I tetramers for the production of T-cell receptor (TCR) mimic antibodies

Demin Li, Carol Bentley, Jenna Yates et al. · PLoS ONE · 2017 · 11 citations · Full text

Life Sciences, Biotechnology, Immunology +17